UC-CARE
Prostate Disease Diagnosis and Treatment
Startup Mature Health Tech & Life Sciences Est. 2004
Total Raised
$1.56M
Mature
Last Round
$1M
2 rounds
Investors
2
1 public
Team
3
11-50 employees
Confidence
91/100
News
4
articles
Patents
1
About
UC-CARE has developed a patented diagnostic and treatment system designed to improve procedures for prostate diseases. The system aims to solve the problem of blind biopsies and to provide an improved system for focal treatment. Navigo is a device that allows physicians to image, plan, place, and record prostate biopsy samples in high-resolution 3D, allowing them to more confidently sample precise areas of the prostate and record biopsy locations for future reference. Navigo Viewer is a CD given to patients upon completion of the procedure. It enables patients and the referring physician to view the procedure summary and keep a record for future follow-ups. SmartBx is a biopsy core preservation and management system that is designed to seamlessly integrate into the TRUS biopsy procedure and contribute to a high cancer-detection rate and improved cancer management, especially for active surveillance processes. Navigo Fusion Studio is a software solution for fusion planning. Its automated algorithms allow radiologists and urologists to quickly prepare images to be processed by Navigo. Cases are automatically sent to the Navigo workstation, streamlining the process from planning to procedure.
Classification
Sector
Health Tech & Life SciencesMedical DevicesDiagnostics DevicesMedical Treatment & Therapeutics
Core Technology
Platforms & InterfacesSoftwareSimulation & Imaging
Target Customer
Healthcare & Life SciencesHealthcareProvidersPatients
Business Model
B2B
Tags
doctorsimagingbiopsyoncologycancermedical-technologiesdiagnosticsmedical-devices3d-technologyhospitalspatientsurologysoftware-developmentoptronicstreatments
Funding & Events
Mar 2019
Undisclosed Round $1M
Florida Funders
Feb 2007
Seed $560K
Meytav Technological Incubator
News (4)
Mar 25, 2019 · www.jewishpresstampa.com
growth-positive
Israeli company gets $1M to expand here - Jewish Press of Tampa
Investment
Sep 26, 2016 · www.prnewswire.com
growth-positive
AXELLA and UC-CARE Announce the Navigo™ and SmartBx™ Systems New cutting edge vision for prostate MRI fusion biopsy
Customers
Feb 19, 2007 · en.globes.co.il
growth-positive
Meytav incubator plans to raise $37m in 2007
Investment
Apr 20, 2006 · www.globes.co.il
growth-positive
Prostate treatment revolution
CustomersInvestment
Details
Product Stage
Released
Employees
11-50
Exact Count
17
District
North District
Founded
2004
Registrar
513550871
Locations
HaTamar 2, Yokne'am Illit, Israel
Tampa, Florida, USA
Links
Website
LinkedIn
Twitter
Admin
Last Update
Sep 7, 2024
Verified by
Sharon Shapira
Missing
markets, not claimed
Team (3)
Tomer Schatzberger
CEO
Shaike Schatzberger
Founder
Founder
Gil Hershkowitz
VP Sales & Marketing